- Home
- TSAT vs LUNG Comparison
TSAT vs LUNG Comparison
Compare TSAT & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSAT
- LUNG
- Stock Information
- Founded
- TSAT 1969
- LUNG 1995
- Country
- TSAT Canada
- LUNG United States
- Employees
- TSAT N/A
- LUNG N/A
- Industry
- TSAT Metal Fabrications
- LUNG Industrial Specialties
- Sector
- TSAT Industrials
- LUNG Health Care
- Exchange
- TSAT Nasdaq
- LUNG Nasdaq
- Market Cap
- TSAT 233.1M
- LUNG 124.0M
- IPO Year
- TSAT 1996
- LUNG 2020
- Fundamental
- Price
- TSAT $23.41
- LUNG $2.87
- Analyst Decision
- TSAT
- LUNG Buy
- Analyst Count
- TSAT 0
- LUNG 6
- Target Price
- TSAT N/A
- LUNG $11.53
- AVG Volume (30 Days)
- TSAT 165.1K
- LUNG 317.8K
- Earning Date
- TSAT 08-13-2025
- LUNG 07-30-2025
- Dividend Yield
- TSAT N/A
- LUNG N/A
- EPS Growth
- TSAT N/A
- LUNG N/A
- EPS
- TSAT N/A
- LUNG N/A
- Revenue
- TSAT $372,642,710.00
- LUNG $87,473,000.00
- Revenue This Year
- TSAT N/A
- LUNG $18.02
- Revenue Next Year
- TSAT N/A
- LUNG $18.17
- P/E Ratio
- TSAT N/A
- LUNG N/A
- Revenue Growth
- TSAT N/A
- LUNG 19.84
- 52 Week Low
- TSAT $7.21
- LUNG $2.50
- 52 Week High
- TSAT $27.45
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- TSAT 65.95
- LUNG 39.07
- Support Level
- TSAT $25.26
- LUNG $2.62
- Resistance Level
- TSAT $27.45
- LUNG $2.88
- Average True Range (ATR)
- TSAT 1.70
- LUNG 0.17
- MACD
- TSAT 0.01
- LUNG 0.05
- Stochastic Oscillator
- TSAT 66.48
- LUNG 39.68
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.